Tre (< 1%) ud af 409 patienter i degarelix gruppen og fire (2%) ud af 201 patienter i leuprorelin 7, 5 mg gruppen havde et QTcF ≥ 500 msek.
Three (< 1%) out of 409 patients in the degarelix group and four (2%) out of 201 patients in the leuprorelin 7.5 mg group, had a QTcF ≥ 500 msec.